Opioid-induced Respiratory Depression
📧 Sign up to get email alerts when something new happens for Opioid-induced Respiratory Depression.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-06-09FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved Naloxone hydrochloride under an Original Application from Mylan Institutional LLC, establishing a generic naloxone product.
-
FDA approval · 2017-07-26FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for Naloxone Hydrochloride (generic) from Somerset Therapeutics, LLC.
-
FDA approval · 2015-03-12FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for naloxone hydrochloride, a generic product, under ANDA070299.